Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
126,404,443
-
Total 13F shares
-
3,847,640
-
Share change
-
-214,419
-
Total reported value
-
$12,393,195
-
Price per share
-
$3.23
-
Number of holders
-
50
-
Value change
-
-$1,227,774
-
Number of buys
-
25
-
Number of sells
-
18
Institutional Holders of Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO) as of Q1 2020
As of 31 Mar 2020,
Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,847,640 shares.
The largest 10 holders included
Prosight Management, LP, BlackRock Inc., GRANAHAN INVESTMENT MANAGEMENT INC/MA, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, HUSSMAN STRATEGIC ADVISORS, INC., STATE STREET CORP, BANK OF MONTREAL /CAN/, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.